Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report - Scorecard - MDSpire

Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report

  • By

  • Xiaoming Li

  • Daiying Gui

  • Chen Xie

  • Yunhong Xia

  • June 29, 2026

  • 0 min

Share

Clinical Scorecard: Choriocarcinoma of Non-Gestational Origin Manifesting as Cervical Lymphadenopathy in a Male: A Case Study

At a Glance

CategoryDetail
ConditionNon-Gestational Choriocarcinoma (NGCC)
Key MechanismsHighly aggressive malignancy with rapid disease progression and elevated serum β-hCG levels.
Target PopulationMale patients, particularly those presenting with unexplained cervical lymphadenopathy.
Care SettingOncology and diagnostic imaging.

Key Highlights

  • NGCC is a rare malignancy in males, accounting for less than 0.1% of testicular tumors.
  • Cervical lymphadenopathy can be the initial manifestation, complicating diagnosis.
  • Histopathological and immunohistochemical analysis are crucial for diagnosis.
  • Platinum-based chemotherapy can lead to transient responses but may be followed by disease progression.
  • Early recognition and comprehensive evaluation are essential to reduce diagnostic delays.

Guideline-Based Recommendations

Diagnosis

  • Include NGCC in the differential diagnosis for unexplained cervical lymphadenopathy in males.
  • Utilize immunohistochemical analysis and imaging studies for accurate diagnosis.

Management

  • Initiate platinum-based chemotherapy upon diagnosis of NGCC.

Monitoring & Follow-up

  • Regular follow-up with serum β-hCG levels and imaging to assess treatment response and disease progression.

Risks

  • High risk of rapid metastasis and disease progression.

Patient & Prescribing Data

Males presenting with cervical lymphadenopathy and elevated β-hCG levels.

Initial treatment with EP chemotherapy showed partial response but was followed by disease progression.

Clinical Best Practices

  • Consider NGCC in differential diagnoses for male patients with atypical lymphadenopathy.
  • Perform comprehensive imaging and histopathological evaluations to guide diagnosis and treatment.

Related Resources & Content

Original Source(s)

Related Content